Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
Public ClinicalTrials.gov record NCT01313572. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The ASPECT2 Trial: A Phase 3, Randomized, Double-Blind Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see whether apadenoson is as effective as adenosine when used as a pharmacological stress agent in myocardial SPECT-imaging (SPECT-MPI)to detect defects in the supply of blood to the heart muscle (myocardial perfusion defects). The study will also look at whether apadenoson is better tolerated than adenosine when used in SPECT-MPI.
Study identification
- NCT ID
- NCT01313572
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 197 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2011 (Type not available)
- Primary completion
- Apr 2012 (Actual)
- Completion
- Apr 2012 (Actual)
- Last update posted
- May 1, 2012
2011 – 2012
United States locations
- U.S. sites
- 45
- U.S. states
- 21
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 138 | Phoenix | Arizona | 85006 | — |
| Forest Investigative Site 146 | Phoenix | Arizona | 85020 | — |
| Forest Investigative Site 113 | Little Rock | Arkansas | 72204 | — |
| Forest Investigative Site 148 | Beverly Hills | California | 90210 | — |
| Forest Investigative Site 154 | Los Angeles | California | 90048 | — |
| Forest Investigative Site 131 | Mission Viejo | California | 92691 | — |
| Forest Investigative Site 156 | Denver | Colorado | 80206 | — |
| Forest Investigative Site 108 | New Haven | Connecticut | 06510 | — |
| Forest Investigative Site 111 | Newark | Delaware | 19713 | — |
| Forest Investigative Site 101 | Clearwater | Florida | 33756 | — |
| Forest Investigative Site 163 | Daytona Beach | Florida | 32117 | — |
| Forest Investigative Site 135 | Edgewater | Florida | 32141 | — |
| Forest Investigative Site 102 | Inverness | Florida | 34452 | — |
| Forest Investigative Site 151 | Jacksonville | Florida | 32209 | — |
| Forest Investigative Site 105 | Melbourne | Florida | 32901 | — |
| Forest Investigative Site 143 | Melbourne | Florida | 32901 | — |
| Forest Investigative Site 137 | Miami | Florida | 33136 | — |
| Forest Investigative Site 103 | Miami | Florida | 33173 | — |
| Forest Investigative Site 123 | Naples | Florida | 34119 | — |
| Forest Investigative Site 161 | Safety Harbor | Florida | 34695 | — |
| Forest Investigative Site 118 | Cumming | Georgia | 30041 | — |
| Forest Investigative Site 119 | Tucker | Georgia | 30084 | — |
| Forest Investigative Site 166 | Covington | Louisiana | 70433 | — |
| Forest Investigative Site 109 | Hammond | Louisiana | 70403 | — |
| Forest Investigative Site 122 | Slidell | Louisiana | 70458 | — |
| Forest Investigative Site 121 | Auburn | Maine | 04210 | — |
| Forest Investigative Site 124 | Annapolis | Maryland | 21401 | — |
| Forest Investigative Site 149 | Hollywood | Maryland | 20636 | — |
| Forest Investigative Site 104 | Detroit | Michigan | 48201 | — |
| Forest Investigative Site 134 | Detroit | Michigan | 48202 | — |
| Forest Investigative Site 159 | Rochester | Minnesota | 55905 | — |
| Forest Investigative Site 142 | Kansas City | Missouri | 64114 | — |
| Forest Investigative Site 162 | New Brunswick | New Jersey | 08901 | — |
| Forest Investigative Site 125 | Albuquerque | New Mexico | 87108 | — |
| Forest Investigative Site 110 | New York | New York | 10032 | — |
| Forest Investigative Site 153 | Camp Hill | Pennsylvania | 17011 | — |
| Forest Investigative Site 152 | Pittsburgh | Pennsylvania | 15213 | — |
| Forest Investigative Site 120 | Wyomissing | Pennsylvania | 19610 | — |
| Forest Investigative Site 145 | Johnson City | Tennessee | 37604 | — |
| Forest Investigative Site 140 | Nashville | Tennessee | 37203 | — |
| Forest Investigative Site 107 | Houston | Texas | 77024 | — |
| Forest Investigative Site 129 | Houston | Texas | 77070 | — |
| Forest Investigative Site 115 | Plano | Texas | 75024 | — |
| Forest Investigative Site 150 | Tomball | Texas | 77375 | — |
| Forest Investigative Site 144 | Provo | Utah | 84604 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01313572, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 1, 2012 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01313572 live on ClinicalTrials.gov.